Anupendra is building a stealth stage startup around disease. He is advisor or investor to several startups as well as Cornell's McGovern Center. For eleven years, he served as Senior Investment Partner at Siemens Venture Capital / Next47. Anupendra served on the Board of USARAD, Seventh Sense, China Diagnostics (acq by Actis & Orbimed), Sequenom (NASD: SQNM), BioImagene (acq by Roche) and Cylex (acq by Viracor-IBT), Novira Therapeutics (acq by J&J ) and Reflectance (acq by Zoll). He spent five years at Global VP of Growth & BD at Siemens Healthineers and Director of Mergers & Acquisitions for Siemens. He actively mentors entrepreneurs as the Founder of the Startup Leadership Program, the world's first global accelerator, which has educated nearly 4,000 entrepreneurs and innovators in 28 cities in 14 countries since 2006 and raised more than $3.4 billion. Anupendra co-founded Harvard Medical School’s Healthcare Innovation & Commercialization program, a very popular course for 800 MDs, PhDs, Postdocs and Faculty about ideation to spin-out. Anupendra holds an MBA from Cornell, Masters in Accounting & Finance from Manchester Business School, and Masters in Economics and Bachelors of Instrumentation Engineering from BITS Pilani.